Back to discover

Protein / target

Bone morphogenetic protein 2

Encoded byBMP2P12643Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Structure with Ligand
1
Research papers

Protein at a glance

Biological role

Phosphatase activator

Strongest disease association

Glaucoma

Via encoding gene BMP2 · Genetic evidence · score 0.84

Research activity

Emerging research

1 papers · latest 2025

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including cardiogenesis, neurogenesis, and osteogenesis.

View complete UniProt function annotation

Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including cardiogenesis, neurogenesis, and osteogenesis (PubMed:18436533, PubMed:24362451, PubMed:31019025). Induces cartilage and bone formation (PubMed:3201241). Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2 (PubMed:15064755, PubMed:17295905, PubMed:18436533). Once all three components are bound together in a complex at the cell surface, BMPR2 phosphorylates and activates BMPR1A (PubMed:7791754). In turn, BMPR1A propagates signal by phosphorylating SMAD1/5/8 that travel to the nucleus and act as activators and repressors of transcription of target genes. Also acts to promote expression of HAMP, via the interaction with its receptor BMPR1A/ALK3 (PubMed:31800957). Can also signal through non-canonical pathways such as ERK/MAP kinase signaling cascade that regulates osteoblast differentiation (PubMed:16771708, PubMed:20851880). Also stimulates the differentiation of myoblasts into osteoblasts via the EIF2AK3-EIF2A-ATF4 pathway by stimulating EIF2A phosphorylation which leads to increased expression of ATF4 which plays a central role in osteoblast differentiation (PubMed:24362451). Acts as a positive regulator of odontoblast differentiation during mesenchymal tooth germ formation, expression is repressed during the bell stage by MSX1-mediated inhibition of CTNNB1 signaling (By similarity)

Subcellular location

Secreted
Domains and Gene Ontology detail (100)

Gene Ontology

  • CBMP receptor complex
  • Ccell surface
  • Cextracellular region
  • Cextracellular space
  • Cprotein-containing complex
  • FBMP receptor binding
  • Fco-receptor binding
  • Fcytokine activity
  • Fgrowth factor activity
  • Fphosphatase activator activity
  • Fsignaling receptor binding
  • Panimal organ morphogenesis

396 aa · 45 kDa

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Cell proliferation & survivalGOGrowth-factor signallingGOCell migrationGOTranscriptional regulationUniProt · GOImmune signallingGOCell adhesionGO
View supporting evidence

Cell proliferation & survival

  • ·negative regulation of cell population proliferation
  • ·positive regulation of cell population proliferation

Growth-factor signalling

  • ·negative regulation of insulin-like growth factor receptor signaling pathway

Cell migration

  • ·positive regulation of cell migration

Transcriptional regulation

  • ·Growth factor of the TGF-beta superfamily that plays essential roles in many development…
  • ·gene expression
  • ·negative regulation of DNA-templated transcription
  • ·negative regulation of gene expression

Immune signalling

  • ·cytokine activity
  • ·inflammatory response
  • ·negative regulation of calcium-independent cell-cell adhesion
  • ·negative regulation of fat cell differentiation

Cell adhesion

  • ·negative regulation of calcium-independent cell-cell adhesion
  • ·positive regulation of extracellular matrix constituent secretion

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene BMP2

Gene-level evidence surfaced through the gene BMP2 that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Glaucoma
0.84Well supported

Genetic evidence dominant · Open Targets 0.51

Glaucoma, Open-Angle
0.84Well supported

Genetic evidence dominant · Open Targets 0.51

Atrial Fibrillation
0.78Well supported

Genetic evidence dominant · Open Targets 0.48

View evidence synthesis (3)
GlaucomaWell supported
0.84
agreement 0.700.98
Genetic99%Literature1%

Open Targets aggregate 0.51 · 2 independent evidence families

Glaucoma, Open-AngleWell supported
0.84
agreement 0.700.98
Genetic99%Literature1%

Open Targets aggregate 0.51 · 2 independent evidence families

Atrial FibrillationWell supported
0.78
agreement 0.640.92
Genetic87%Literature13%

Open Targets aggregate 0.48 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Glaucoma0.51
Glaucoma, Open-Angle0.51
Atrial Fibrillation0.48

Tractability

Small moleculesEmerging

Feasibility evidence (structure with ligand) — no clinical-stage drug of this modality recorded.

AntibodiesEmerging

Feasibility evidence (go cc high conf and uniprot loc med conf) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (database ubiquitination) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (5)
SM · Structure with LigandAB · GO CC high confAB · UniProt loc med confAB · UniProt SigP or TMHMMPR · Database Ubiquitination

Raw Open Targets tractability assessment buckets, by modality.

Research activity

1 papers · to 2025

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Recent

Europe PMC papers linked directly to this protein.

Related family literature

2

Papers about “Bone Morphogenetic Proteins” — a broader family this protein belongs to. Shown as context; not counted as papers specifically about this protein.

The modulatory role of bone morphogenetic protein signaling in cerebellar synaptic plasticity.

Hirono M · Journal of neurochemistry · 2025

via Bone Morphogenetic Proteins

Sclerostin and Cardiovascular Disease.

Tobias JH · Current osteoporosis reports · 2023

via Bone Morphogenetic Proteins

Europe PMC literature, reached through curated HGNC family membership. Membership is a taxonomic relationship — it does not imply this protein participates in every mechanism these papers discuss.